[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,235
  • Shares Outstanding, K 46,489
  • Annual Sales, $ 8,980 K
  • Annual Income, $ -48,790 K
  • EBIT $ -54 M
  • EBITDA $ -53 M
  • 60-Month Beta 0.82
  • Price/Sales 4.61
  • Price/Cash Flow N/A
  • Price/Book 1.32
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings $-0.17 on 08/14/26
  • Next Earnings Date 11/03/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Options Overview Details

View History
  • Implied Volatility 394.91% (-245.50%)
  • Historical Volatility 73.79%
  • IV Percentile 48%
  • IV Rank 38.03%
  • IV High 991.35% on 08/03/26
  • IV Low 28.94% on 09/04/25
  • Expected Move (DTE 16) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 477
  • Open Int (30-Day) 564
  • Expected Range 0.8700 to 0.8700

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.15
  • Number of Estimates 1
  • High Estimate $-0.15
  • Low Estimate $-0.15
  • Prior Year $-0.17
  • Growth Rate Est. (year over year) +11.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6500 +36.15%
on 08/03/26
1.0200 -13.24%
on 08/14/26
+0.2350 (+36.15%)
since 07/31/26
3-Month
0.6300 +40.48%
on 06/26/26
1.0300 -14.08%
on 06/03/26
-0.1250 (-12.38%)
since 06/02/26
52-Week
0.6300 +40.48%
on 06/26/26
2.5650 -65.50%
on 10/06/25
-1.5450 (-63.58%)
since 09/02/25

Most Recent Stories

More News
InspireMD Reports Second Quarter 2026 Financial Results

- Company to host investor conference call today, August 17th, at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR)...

NSPR : 0.8573 (-5.64%)
InspireMD to Announce Second Quarter 2026 Financial Results

MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent...

NSPR : 0.8573 (-5.64%)
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today...

NSPR : 0.8573 (-5.64%)
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing

Ms. Kennedy returns to InspireMD having previously served as Sales Director supporting the initial U.S. ...

NSPR : 0.8573 (-5.64%)
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIAMI, June 12, 2026 (GLOBE NEWSWIRE) --  InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent...

NSPR : 0.8573 (-5.64%)
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent...

NSPR : 0.8573 (-5.64%)
InspireMD Reports First Quarter 2026 Financial Results

            - Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the...

NSPR : 0.8573 (-5.64%)
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% - ...

NSPR : 0.8573 (-5.64%)
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent...

NSPR : 0.8573 (-5.64%)
InspireMD to Announce First Quarter 2026 Financial Results

MIAMI, April 27, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of...

NSPR : 0.8573 (-5.64%)

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

3rd Resistance Point 0.9932
2nd Resistance Point 0.9508
1st Resistance Point 0.9297
Last Price 0.8573
1st Support Level 0.8662
2nd Support Level 0.8238
3rd Support Level 0.8027

See More

52-Week High 2.5650
Fibonacci 61.8% 1.8258
Fibonacci 50% 1.5975
Fibonacci 38.2% 1.3692
Last Price 0.8573
52-Week Low 0.6300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.